Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
Monster Beverage
MNST
|
$396M |
| 5 |
argenx
ARGX
|
$306M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Regal Rexnord
RRX
$9.91B
| $219M | 0.14% | 1,556,578 -51,678 | -3% | -$7.27M |
|
152
United Therapeutics
UTHR
$13.8B
| $219M | 0.14% | 975,830 +208,404 | +27% | +$46.7M |
|
153
Johnson & Johnson
JNJ
$427B
| $218M | 0.14% | 1,404,862 -97,626 | -6% | -$15.1M |
|
154
Deckers Outdoor
DECK
$17.7B
| $217M | 0.14% | 483,581 -333,782 | -41% | -$150M |
|
155
TSMC
TSM
$1.2T
| $214M | 0.14% | 2,296,015 +105,009 | +5% | +$9.77M |
|
156
Canadian Natural Resources
CNQ
$65.9B
| $212M | 0.14% | 3,839,502 +281,329 | +8% | +$15.6M |
|
157
Rockwell Automation
ROK
$38.6B
| $211M | 0.14% | 719,355 +1,314 | +0.2% | +$386K |
|
158
Elevance Health
ELV
$71.8B
| $208M | 0.14% | 452,180 +4,436 | +1% | +$2.04M |
|
159
Coca-Cola
KO
$297B
| $204M | 0.13% | 3,292,671 -307,632 | -9% | -$19.1M |
|
|
PXD
160
DELISTED
Pioneer Natural Resource Co.
PXD
| $203M | 0.13% | 992,554 +306,009 | +45% | +$62.5M |
|
161
Vanguard S&P 500 ETF
VOO
$726B
| $202M | 0.13% | 537,812 +160,348 | +42% | +$60.3M |
|
162
Occidental Petroleum
OXY
$46.9B
| $202M | 0.13% | 3,238,511 +835,772 | +35% | +$52.2M |
|
163
Neurocrine Biosciences
NBIX
$13.8B
| $202M | 0.13% | 1,994,521 -421,117 | -17% | -$42.6M |
|
164
Sensient Technologies
SXT
$4.82B
| $199M | 0.13% | 2,604,266 +4,243 | +0.2% | +$325K |
|
165
Sempra
SRE
$53.9B
| $199M | 0.13% | 1,313,687 +234,061 | +22% | +$35.4M |
|
166
Alliant Energy
LNT
$16.7B
| $196M | 0.13% | 3,670,327 +25,371 | +0.7% | +$1.35M |
|
167
Palo Alto Networks
PANW
$127B
| $196M | 0.13% | 980,104 +530,604 | +118% | +$106M |
|
168
Blackbaud
BLKB
$3.24B
| $192M | 0.13% | 2,765,818 -41,706 | -1% | -$2.89M |
|
|
HZNP
169
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $190M | 0.13% | 1,738,146 -2,211,373 | -56% | -$241M |
|
170
Tyler Technologies
TYL
$24.4B
| $189M | 0.12% | 531,659 -82,937 | -13% | -$29.4M |
|
171
AstraZeneca
AZN
$248B
| $186M | 0.12% | 2,675,415 -376,276 | -12% | -$26.1M |
|
172
Autodesk
ADSK
$67.3B
| $183M | 0.12% | 877,818 -143,825 | -14% | -$29.9M |
|
173
Core & Main
CNM
$12.3B
| $181M | 0.12% | 7,844,638 +31,789 | +0.4% | +$734K |
|
174
STAG Industrial
STAG
$6.88B
| $179M | 0.12% | 5,298,930 +173,697 | +3% | +$5.87M |
|
175
OSI Systems
OSIS
$3.87B
| $179M | 0.12% | 1,749,330 -83,002 | -5% | -$8.5M |
|